Jason Sicklick (@jasonsicklick) 's Twitter Profile
Jason Sicklick

@jasonsicklick

Professor of Surgery & Pharmacology at UC San Diego. Surgical Oncologist. Surgeon-Scientist. Exec VC of Research. “Views expressed are my own personal beliefs”

ID: 958538148971196417

linkhttp://profiles.ucsd.edu/jason.sicklick calendar_today31-01-2018 03:11:18

506 Tweet

1,1K Followers

1,1K Following

CTOS (@ctosociety) 's Twitter Profile Photo

A session that everyone is waiting for each year - a Debate! Prevent drug resistance through earlier combination Tx 🆚 Target drug resistance when it develops? Sebastian Bauer 🥊🥊Meg von Mehren Who will be the winner? ⏱️check today at 11.30 am #CTOS2024 #CTOSTweeTOS

A session that everyone is waiting for each year - a Debate!
Prevent drug resistance through earlier combination Tx 🆚 Target drug resistance when it develops?
Sebastian Bauer 🥊🥊Meg von Mehren
Who will be the winner?
⏱️check today at 11.30 am
#CTOS2024 #CTOSTweeTOS
Priya Chudasama (@priyachudasama5) 's Twitter Profile Photo

It starts! #CTOS2024 is officially underway with a helluva welcome address by Jason Sicklick and President Damon Reed, also featuring a special guest! Wishing all the #topgunsofsarcoma a great meeting! CTOS

Alessandro Gronchi (@alegronchi) 's Twitter Profile Photo

Stefano Radaelli⁩ presenting at ⁦CTOS⁩ the 3rd interim analysis of the SACRO study. With a 4yr median FU heavy particles definitive radiotherapy is not inferior to surgery in 128 patients affected by sacral chordoma. Great study. More FU is needed! ⁦

⁦<a href="/radaste/">Stefano Radaelli</a>⁩ presenting at ⁦<a href="/ctosociety/">CTOS</a>⁩ the 3rd interim analysis of the SACRO study. With a 4yr median FU heavy particles definitive radiotherapy is not inferior to surgery in 128 patients affected by sacral chordoma. Great study. More FU is needed! ⁦
Pawel Sobczuk (@pawel_sobczuk) 's Twitter Profile Photo

Congrats 👏👏 Fabio Tirotta go tremendous effort to define benchmark values for reservation of retroperitoneal liposarcoma 🔜movening towards better quality and better patients outcomes #CTOS2024 #CTOSTweeTOS CTOS TARPSWG

Congrats 👏👏 <a href="/TirottaFabio/">Fabio Tirotta</a> go tremendous effort to define benchmark values for reservation of retroperitoneal liposarcoma
🔜movening towards better quality and better patients outcomes
#CTOS2024 #CTOSTweeTOS <a href="/ctosociety/">CTOS</a> <a href="/TARPSWG/">TARPSWG</a>
Tannaz Ranjbarian (@taranjbarian) 's Twitter Profile Photo

Inspiration & insight! Thank you, CTOS Conference, for the opportunity to share our research. CTOS #CTOS2024 Learning from the best! Honored to share this experience with my attending professor Dr. Jason Sicklick

Inspiration &amp; insight! Thank you, CTOS Conference, for the opportunity to share our research. <a href="/ctosociety/">CTOS</a> #CTOS2024 Learning from the best! Honored to share this experience with my attending professor Dr. <a href="/JasonSicklick/">Jason Sicklick</a>
Patrick Schöffski (@schoffski) 's Twitter Profile Photo

Excellent media coverage at the Annual CTOS meeting 2024. In-depth interview of the presenter of Brightline-1 trial by the great Ron Burgundy from KVWN Channel 4, just after he gave the N. Axelrad lecture. What a multi-talented anchorman! You stay classy, San Diego…

Excellent media coverage at the Annual CTOS meeting 2024. In-depth interview of the presenter of Brightline-1 trial by the great Ron Burgundy from KVWN Channel 4, just after he gave the N. Axelrad lecture. What a multi-talented anchorman! You stay classy, San Diego…
Society of Surgical Oncology (@socsurgonc) 's Twitter Profile Photo

Don't forget to mark your calendar and claim your spot in this insightful webinar reviewing important new data and discussing updates on the treatment of gastrointestinal stromal tumors (GIST). Jason Sicklick Neeta Somaiah, MD Breelyn Wilky, MD 🎗 Register Now: ow.ly/lZWb50U86f3

Don't forget to mark your calendar and claim your spot in this insightful webinar reviewing important new data and discussing updates on the treatment of gastrointestinal stromal tumors (GIST). <a href="/JasonSicklick/">Jason Sicklick</a> <a href="/NeetaSomaiahMD/">Neeta Somaiah, MD</a> <a href="/breelynwilkyMD/">Breelyn Wilky, MD 🎗</a>

Register Now: ow.ly/lZWb50U86f3
CTOS (@ctosociety) 's Twitter Profile Photo

#CTOS2025 registration and abstract submission system is open! 🎉Don't miss the biggest #sarcoma meeting and unique celebration of CTOS's 30th anniversary! 🗓️ We are waiting for your abstracts until Jun 20th! More details on the meeting website ⏩ ctos.org/Meeting/2025An…

#CTOS2025 registration and abstract submission system is open!

🎉Don't miss the biggest #sarcoma meeting and unique celebration of CTOS's 30th anniversary!
🗓️ We are waiting for your abstracts until Jun 20th!

More details on the meeting website ⏩
ctos.org/Meeting/2025An…
UC San Diego Surgery (@ucsdsurgery) 's Twitter Profile Photo

Congratulations Mark Antkowiak, M.D., general surgery resident, on receiving the Society of Surgical Oncology Harvey Baker Traveling Fellow Award. Antkowiak will receive $1,000 in travel support for his work on gene expression in gastrointestinal stromal tumors. 🏆#UCSDSurgery #SurgicalOncology

Congratulations Mark Antkowiak, M.D., general surgery resident, on receiving the <a href="/SocSurgOnc/">Society of Surgical Oncology</a> Harvey Baker Traveling Fellow Award. Antkowiak will receive $1,000 in travel support for his work on gene expression in gastrointestinal stromal tumors. 🏆#UCSDSurgery #SurgicalOncology
Vivek Subbiah, MD (@viveksubbiah) 's Twitter Profile Photo

🚨🥁Exciting Nature Medicine Publication Announcement 👉Hot off the press on this #ClinicalTrialsDay ! Thrilled to share our Nature Medicine paper: "Cancer treatment paradigms in the precision medicine era" 👉We propose 5 BOLD strategic recommendations to modernize cancer

🚨🥁Exciting Nature Medicine Publication Announcement 
👉Hot off the press on this #ClinicalTrialsDay ! 
Thrilled to share our <a href="/NatureMedicine/">Nature Medicine</a> paper: 
"Cancer treatment paradigms in the precision medicine era"
👉We propose 5 BOLD strategic recommendations to modernize cancer
UC San Diego Surgery (@ucsdsurgery) 's Twitter Profile Photo

That's a wrap on the @UCSDSurgery 13th Annual Surgery Research Symposium! Congratulations to all of our presenters, and thank you to Martha Zeiger MD, M.D., for your keynote speech on the surgeon-scientist as a leader. Looking forward to next year! 🥼 #UCSDSurgery #Research

That's a wrap on the @UCSDSurgery 13th Annual Surgery Research Symposium! Congratulations to all of our presenters, and thank you to <a href="/mzeigermd/">Martha Zeiger MD</a>, M.D., for your keynote speech on the surgeon-scientist as a leader. Looking forward to next year! 🥼 #UCSDSurgery #Research